Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History RZLT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics RZLT

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Rezolute Inc

RZLT
Current price
4.98 USD +0.18 USD (+3.75%)
Last closed 4.82 USD
ISIN US76200L3096
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 418 446 880 USD
Yield for 12 month +20.00 %
1Y
3Y
5Y
10Y
15Y
RZLT
21.11.2021 - 28.11.2021

Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States. The company's lead product candidate is ersodetug, a human monoclonal antibody that is in Phase 3 clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder. It also developing RZ402, an oral plasma kallikrein inhibitor, which is in Phase 2 clinical trial for the chronic treatment of diabetic macular edema. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was incorporated in 2010 and is headquartered in Redwood City, California. Address: 275 Shoreline Drive, Redwood City, CA, United States, 94065

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

13.11 USD

P/E Ratio

Dividend Yield

Financials RZLT

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures RZLT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-36 000 USD

Last Year

-382 000 USD

Current Quarter

Last Quarter

EBITDA -77 116 000 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -52.85 %
PEG Ratio
Return On Equity TTM -95.16 %
Wall Street Target Price 13.11 USD
Revenue TTM
Book Value 1.36 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -1.16 USD
Diluted Eps TTM -1.16 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation RZLT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -0.011
Price Book MRQ 5.11

Technical Indicators RZLT

For 52 Weeks

2.22 USD 6.19 USD
50 Day MA 4.07 USD
Shares Short Prior Month 4 427 801
200 Day MA 4.41 USD
Short Ratio 5.94
Shares Short 5 141 077
Short Percent 7.20 %